September 2nd, 2010
Less Intensive First-Line Therapy Appears Effective for Early Hodgkin Lymphoma
Hayes OVERVIEW
Hayes Overview
Industry leader in providing unbiased, evidence-based health technology assessment reports of new, emerging, and controversial health technologies. Hayes’ worldwide clients include hospitals, healthcare systems, government agencies, employers, and managed care organizations.
Hayes ANALYTICS
Hayes Analytics
Evidence-based analyses to support development of defensible, transparent coverage policies, care management protocols, and best practice guidelines for managed care organizations and government agencies.
Hayes INSIGHT
Hayes Insights
Evidence-based information and consulting services to support hospitals and healthcare systems in selecting, deploying, and implementing new healthcare technologies.
Hayes CARE
Hayes Care
An innovative workplace benefit to help your employees and their families make better healthcare decisions and cope with disruptive health events.
> OUR MISSION
The Hayes mission is to drive better healthcare decisions. Hayes research products and advisory services are used by some of the world’s leading healthcare organizations. Our clients include payers developing coverage policies, hospitals making health technology acquisition decisions, and employers helping employees make better healthcare choices.
> VIDEOS
Hayes Analytics
Hayes Insight
Hayes Care
> WHAT’S NEW
> HAYES HIGHLIGHTS
Concerns About Rapid Adoption of Robotic Technology
Expert Insight on Genetic Tests Marketed Directly to Consumers
FDA Proposed Increasing its Regulatory Oversight of LDTs
Key themes emerged from the FDA’s 2-day meeting on Laboratory-Developed Tests.